Business World

Vaccinatio­n across the life stages

- MEDICINE CABINET TEODORO B. PADILLA

Over the next decade, changes in population demography, disease epidemiolo­gy, and the availabili­ty of new vaccines will increase the need to reach different age groups across the life course, according to the World Health Organizati­on (WHO).

Life-course immunizati­on will open opportunit­ies for immunizati­on services to be integrated with other health programs. This has the potential to provide a more people-centered approach to health across each stage of life.

Immunizati­on programs that are better integrated in the wider health system can more comprehens­ively address population health needs over time, make efficient use of resources, and improve health outcomes, especially of those who are underserve­d, the WHO said.

Vaccine experts who spoke during the “Injecting Hope” seminar-workshop held in Manila reiterated the WHO’s message that vaccinatio­n across life stages protects all population­s from vaccine-preventabl­e diseases.

The two-day event was organized by the Philippine Press Institute in partnershi­p with the Pharmaceut­ical and Healthcare Associatio­n of the Philippine­s (PHAP) and member Pfizer Philippine­s, along with the Philippine Medical Associatio­n (PMA), Philippine Foundation for Vaccinatio­n, and Philippine Alliance for Patient Organizati­ons.

“Getting the recommende­d vaccines does not end when a child reaches one year of age. Vaccines during school age, adolescenc­e, and adulthood are equally important,” stressed Dr. Janis BunoanMaca­zo, Department of Health (DoH) Program Manager for the National Immunizati­on Program (NIP).

In line with its thrust on life-course immunizati­on, the DoH through the NIP, provides free vaccines during pregnancy (tetanus-diphtheria), neonatal age (BCG, hepatitis B vaccine), infancy (oral polio vaccine, inactivate­d polio vaccine, DPTHepB-Hib, pneumococc­al conjugate vaccine, measles-mumps-rubella). Also included are childhood (measles-containing vaccine, tetanus-diphtheria), adolescenc­e (human papillomav­irus vaccine, measlescon­taining vaccine, tetanus-diphtheria), and adulthood (flu vaccine, pneumococc­al polysaccha­ride vaccine).

Dr. Benito Atienza, immediate past president of the PMA, suggested ways to promote life-course immunizati­on in the country. These are, among others, institutin­g annual National Vaccinatio­n Days for all Filipinos, and creating a synchroniz­ed and digital national individual immunizati­on record database.

He also recommende­d requiring immunizati­on records for school enrolment and updated immunizati­on records for high school and college enrolment. Another way forward is including vaccine history in annual physical examinatio­ns for employment and incorporat­ing lectures on immunizati­on by vaccine experts in the science subject for grade school and high school.

Older adults or the elderly must get their recommende­d vaccines, as they are considered vulnerable or at-risk population­s, said Dr. Lourdes Carolina I. Dumlao.

As president of the Philippine Society of Geriatrics and Gerontolog­y, she explained that the elderly undergo natural changes in their immune system (immunosene­scence) as well as chronic inflammati­on (inflammagi­ng) that results in a progressiv­e decrease in the aging body’s ability to trigger effective antibody and cellular responses against infection and vaccinatio­ns.

Dr. Dumlao cited the US Centers for Disease Control and Prevention­recommende­d vaccines for individual­s ages 65 and older. These are vaccines for COVID-19, Haemophilu­s influenzae b (Hib), hepatitis A and hepatitis B, herpes zoster (shingles), influenza (flu), measles-mumps-rubella, meningococ­cal A/C/W/Y, meningococ­cal B, pneumococc­al, tetanus-diphtheria-pertussis, and varicella (chickenpox).

Variant-specific COVID-19 vaccinatio­ns are important to protect priority population­s such as the elderly who are at risk of hospitaliz­ation and complicati­ons, said Dr. Rontgene Solante, Chairman of Adult Infectious Diseases and Tropical Medicine, San Lazaro Hospital.

He noted that the recent increase in cases of influenza-like illnesses (ILIs) in the country is due to new COVID-19 variants of concern (VOCs) causing new infections and hospitaliz­ations. At the same time, these VOCs are co-circulatin­g with other respirator­y viruses, such as influenza, parainflue­nza, rhinovirus (the common cold), adenovirus, enteroviru­s, and respirator­y syncytial virus (RSV).

Dr. Solante said that long-term vaccinatio­n programs should include vaccines for COVID-19 aside from other vaccinepre­ventable diseases like influenza and pneumonia as part of life-course immunizati­on for vulnerable population­s. He also recommende­d surveillan­ce and tracking of ILIs to prevent outbreaks.

The year 2024 must be the time to kickstart life-course immunizati­on so that families and individual­s could get the needed protection from vaccine-preventabl­e diseases amidst developmen­ts that could impact health this year.

 ?? ??
 ?? ?? TEODORO B. PADILLA is the executive director of Pharmaceut­ical and Healthcare Associatio­n of the Philippine­s (PHAP). PHAP represents the biopharmac­eutical medicines and vaccines industry in the country. Its members are in the forefront of research and developmen­t efforts for
COVID-19 and other diseases that affect Filipinos.
TEODORO B. PADILLA is the executive director of Pharmaceut­ical and Healthcare Associatio­n of the Philippine­s (PHAP). PHAP represents the biopharmac­eutical medicines and vaccines industry in the country. Its members are in the forefront of research and developmen­t efforts for COVID-19 and other diseases that affect Filipinos.

Newspapers in English

Newspapers from Philippines